申请人:Novira Therapeutics, Inc.
公开号:US20150225355A1
公开(公告)日:2015-08-13
Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
本文提供了一些用于治疗HBV感染的化合物,以及其药物组合物和抑制、抑制或预防受试者HBV感染的方法。